Hypercholesterolemia and Mixed Dyslipidemia
1 clinical trials · Condition
◉ Watch Hypercholesterolemia and Mixed Dyslipidemia
| Record | Firm | Date |
|---|---|---|
| A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia (NCT07278830) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2023-06-02 |
Track Hypercholesterolemia and Mixed Dyslipidemia automatically
Every clearance here is in the API, with alerts when new ones post.